TuHURA Biosciences, Inc. (HURA)
TuHURA Biosciences, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Tampa, FL, US. The stock last traded at $2.30, up 6.98% on the session, giving a market capitalisation of $146.5M. On trailing twelve-month figures it carries a trailing P/E of -3.75, a net margin of 0.0%. Its beta of -0.01 implies it has historically moved less than the broad market.
TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registration stage of clinical development. The company is dedicated to pioneering innovative technologies designed to effectively combat the mechanisms by which cancers develop resistance to existing immunotherapy treatments. Its operations are based in Tampa, Florida.
TuHURA Biosciences, Inc. is most often compared with the following Healthcare names: